INOVIO Set to Present at Key Scientific Conference
INOVIO (NASDAQ: INO), a leading biotechnology firm focused on developing DNA-based treatments, has announced its participation in a notable scientific conference. The aim is to share insights into advancements related to HPV-associated diseases, cancer, and other infectious illnesses.
Details of the Conference Presentation
At the World Congress of Electroporation, INOVIO's oral presentation will be delivered by Trevor Smith, the company’s Vice President of Preclinical R&D. His talk, titled "Development of in vivo-launched synthetic DNA-encoded antibodies employing CELLECTRA electroporation technology," is set for September 18, 2024, from 3:20 PM to 3:35 PM CET.
How to Access the Research
The insights presented are anticipated to enhance the understanding of cutting-edge techniques within the biotechnology arena. After the event, participants can access the abstract on INOVIO's website, which will further highlight the exciting breakthroughs discussed during the conference.
About INOVIO
INOVIO is committed to advancing DNA-based therapies aimed at strengthening the immune response to a variety of health issues, including HPV-related conditions and cancer. Their work revolves around developing effective and safe delivery methods for DNA medicines, enabling the body to produce its own disease-fighting agents through innovative design and delivery approaches.
Company's Vision and Mission
With a focus on driving health innovation, INOVIO strives to maintain its leadership in the biotechnology field. Their dedication to research and development is steadfast, as they explore ways to further enhance DNA medicines for improved patient care and safety.
Contact Information
For media inquiries, please contact Jennie Willson at (267) 429-8567. Investors interested in learning more about the company’s activities and future objectives can reach out to Thomas Hong at (267) 440-4298.
Frequently Asked Questions
What topics will INOVIO cover in its conference presentation?
INOVIO will focus on the development of synthetic DNA-encoded antibodies, particularly using electroporation technology.
When is the exact time of the presentation?
The presentation will take place on September 18, 2024, from 3:20 PM to 3:35 PM CET.
Who will be delivering the presentation for INOVIO?
The presentation will be delivered by Trevor Smith, who is the Vice President of Preclinical R&D at INOVIO.
How can I find the conference abstract?
After the conference, the abstract will be available on INOVIO's official website for those who are interested.
Where can I learn more about INOVIO?
To find additional information about INOVIO, visit their website, where they outline their ongoing projects and innovations in the field of DNA medicines.